within Pharmacolibrary.Drugs.ATC.J;

model J01DC02_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.37,
    Cl             = 4.933333333333333e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0136,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.009333333333333334,
    Tlag           = 840
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DC02_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefuroxime is a second-generation cephalosporin antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. It is used to treat various infections, including respiratory tract, urinary tract, skin and soft tissue infections. Cefuroxime is approved and widely used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral dose of cefuroxime axetil tablet.</p><h4>References</h4><ol><li><p>Albarellos, GA, et al., &amp; Landoni, MF (2020). Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 43(3) 297–302. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12854&quot;>10.1111/jvp.12854</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32157713/&quot;>https://pubmed.ncbi.nlm.nih.gov/32157713</a></p></li><li><p>Foord, RD (1976). Cefuroxime: human pharmacokinetics. <i>Antimicrobial agents and chemotherapy</i> 9(5) 741–747. DOI:<a href=&quot;https://doi.org/10.1128/AAC.9.5.741&quot;>10.1128/AAC.9.5.741</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/949172/&quot;>https://pubmed.ncbi.nlm.nih.gov/949172</a></p></li><li><p>Ruiz-Carretero, P, et al., &amp; Casabo, VG (2000). Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. <i>International journal of pharmaceutics</i> 202(1-2) 89–96. DOI:<a href=&quot;https://doi.org/10.1016/s0378-5173(00)00420-8&quot;>10.1016/s0378-5173(00)00420-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10915930/&quot;>https://pubmed.ncbi.nlm.nih.gov/10915930</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DC02_1;
